APA (7th ed.) Citation

R, L., E, P., GM, M., A, P., S, A., F, B., . . . T, I. (2025). Intensified Induction Therapy for Newly Diagnosed, Localized Skeletal Ewing Sarcoma (ISG/AIEOP EW-1): A Randomized, Open-Label, Phase 3, Non-Inferiority Trial. Pediatric blood & cancer, 72(4), e31551. https://doi.org/10.1002/pbc.31551

Chicago Style (17th ed.) Citation

R, Luksch, et al. "Intensified Induction Therapy for Newly Diagnosed, Localized Skeletal Ewing Sarcoma (ISG/AIEOP EW-1): A Randomized, Open-Label, Phase 3, Non-Inferiority Trial." Pediatric Blood & Cancer 72, no. 4 (2025): e31551. https://doi.org/10.1002/pbc.31551.

MLA (9th ed.) Citation

R, Luksch, et al. "Intensified Induction Therapy for Newly Diagnosed, Localized Skeletal Ewing Sarcoma (ISG/AIEOP EW-1): A Randomized, Open-Label, Phase 3, Non-Inferiority Trial." Pediatric Blood & Cancer, vol. 72, no. 4, 2025, p. e31551, https://doi.org/10.1002/pbc.31551.